zirconium has been researched along with fusigen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decristoforo, C; Franssen, GM; Haas, H; Haubner, R; Laverman, P; Petrik, M; Rangger, C; Summer, D; Zhai, C | 1 |
| Andersson, KG; Decristoforo, C; Garousi, J; Löfblom, J; Mitran, B; Orlova, A; Oroujeni, M; Summer, D; Tolmachev, V; Vorobyeva, A | 1 |
2 other study(ies) available for zirconium and fusigen
| Article | Year |
|---|---|
Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates.
Topics: Chelating Agents; Ferric Compounds; Humans; Hydroxamic Acids; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Zirconium | 2015 |
Cyclic versus Noncyclic Chelating Scaffold for
Topics: Animals; Autoradiography; Cell Line, Tumor; Chelating Agents; Chromatography, High Pressure Liquid; Deferoxamine; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Female; Ferric Compounds; Humans; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radioisotopes; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Xenograft Model Antitumor Assays; Zirconium | 2018 |